Stock Details
4578.T is Otsuka Holdings Co., Ltd.'s stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 4,634.06ï¿¥. Average daily volumn in 3 months 990.7k. Market cap 2.54T



Stock symbol : 4578.T. Exchange : Tokyo. Currency : JPY
Lastest price : 4,689.00ï¿¥. Total volume : 1.07M. Market state PREPRE
Click reload if you want to check the lastest price on market!!!

Otsuka Holdings Co., Ltd. (4578.T)
Last Price
4,689.00ï¿¥
Change
103.00
Volume
1.07M

Previous Close4,586.00
Open4,621.00
Day Range4,613.00-4,697.00
Bid0.00 x N/A
Ask0.00 x N/A
Volume1.07M
Average Volume990.7k
Market Cap2.54T
Beta0.33
52 Week Range3,831.00-5,000.00
Trailing P/E24.50
Foward P/E15.83
Dividend (Yield %)2.18%
Ex-Dividend Date2022-12-29



Financial Details


According to Otsuka Holdings Co., Ltd.'s financial reports the company's revenue in 2021 were 1.5T an increase(0%) over the years 2020 revenue that were of 1.42T. In 2021 the company's total earnings were 125.46B while total earnings in 2020 were 148.14B(-15.54%).


Loading ...



Organization

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCA... RI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.

Market Cap:
2.54T
Revenue:
1.5T
Total Assets:
2.82T
Total Cash:
410.68B


News about "Otsuka Holdings Co., Ltd."

Otsuka Holding

Source from : Forbes - 5 days ago

Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals ...See details»


Otsuka Holdings Ltd (4578)

Source from : Investing - 1 days ago

Otsuka Holdings Co., Ltd. is a Japan-based company mainly engaged in the medical and nutraceuticals related business and other businesses. The Company operates through four business segments.See details»


Otsuka Holdings Co. Ltd.

Source from : Wall Street Journal - 4 days ago

1 Day 4578 -0.07% DJIA -1.71% S&P 500 -1.51% Health Care/Life Sciences 0.20% Ichiro Otsuka Chairman Otsuka Pharmaceutical Factory, Inc., Otsuka Pharmaceutical Co., Ltd., Otsuka Holdings Co., Ltd ...See details»


Taiho’s Lytgobi gets US FDA approval for previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma

Source from : Pharmabiz - 1 days ago

Taiho’s Lytgobi gets US FDA approval for previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma: Princeton, New Jersey Monday, October ...See details»


otsuka-medical-devices-announces-results-of-radiance-ii-pivotal-trial-at-tct-2022-annual-meeting-image

Otsuka Medical Devices Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting

Source from : Yahoo - 14 days ago

Otsuka Medical Devices Co., Ltd. ("Otsuka Medical Devices") a wholly owned subsidiary of Otsuka Holdings today announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating ...See details»


Digital Pills Market Overview 2022 to 2028, Future Trends and Industry Forecast | Proteus Digital Health, Inc, Otsuka Holdings Co.

Source from : MarketWatch - 8 days ago

Download Free Sample Digital Pills Market report The worldwide Digital Pills Market is expected to grow at a booming CAGR of 2022-2030, rising from USD billion in 2021 to USD billion in 2028. It also ...See details»


OTSUKA AND LUNDBECK GENERATE EXPLORATORY DATA IN MAJOR DEPRESSIVE DISORDER BASED ON PATIENT FEEDBACK

Source from : Newswire - 5 days ago

CNW/ - Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc., together with their global teams, presented the headline results of ENGAGE, a ...See details»


Otsuka announces EC approval of Lupkynis® (voclosporin) as first oral treatment for active lupus nephritis

Source from : PharmiWeb - 14 days ago

Otsuka Pharmaceutical Europe Ltd. today announces that the European Commission (EC) has approved Lupkynis® (voclosporin) in combination with mycophenolate mofetil for the treatment of adult patients ...See details»


usd-131-bn-growth-for-urticaria-drugs-market-through-2026-analysing-growth-for-pharmaceuticals-technavio-image

USD 1.31 Bn growth for Urticaria Drugs Market through 2026: Analysing growth for Pharmaceuticals - Technavio

Source from : Yahoo - 5 days ago

The Urticaria Drugs Market report has been added to Technavio's offering. The urticaria drugs market value is anticipated to grow by USD 1.31 billion, at a CAGR of 10.35% during the forecast period.See details»


Vegan Cheese Market Size to Grow at 12.21% CAGR During the Forecast Period of 2022-2027 | 108 Report Pages

Source from : MarketWatch - 7 days ago

Report Pages] Vegan Cheese market size was valued at USD 3740.87 million in 2021 and is expected to expand at a ...See details»


ReCor Medical to Present RADIANCE II US Pivotal Trial Data in Late-Breaking Presentation at TCT Conference

Source from : Benzinga.com - 20 days ago

About ReCor Medical, Inc. ReCor Medical, headquartered in Palo Alto, CA, a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., is a medical technology company focused on transforming the ...See details»


Otsuka Holdings Co. Ltd.

Source from : Wall Street Journal - 5 days ago

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...See details»


Otsuka Holdings Co., Ltd. (OTSKY)

Source from : Yahoo Finance - 6 days ago

Nasdaq plunges 5.1%, S&P 500 plummets 4.3% as inflation triggers Tuesday market meltdown ...See details»


OTSKY Otsuka Holdings Co., Ltd.

Source from : Seeking Alpha - 8 days ago

**NM signifies a non meaningful value. A dash signifies the data is not available.See details»